Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antipsychotic Drug Trifluoperazine Suppresses Colorectal Cancer by Inducing G0/G1 Arrest and Apoptosis
Yong Xia, Chengsen Jia, Qiang Xue, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Regulation of PD-L1 expression on cancer cells with ROS-modulating drugs
Christian Bailly
Life Sciences (2020) Vol. 246, pp. 117403-117403
Closed Access | Times Cited: 80
The potential role of vitamin C in empowering cancer immunotherapy
Takwa Bedhiafi, Varghese Inchakalody, Queenie Fernandes, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112553-112553
Open Access | Times Cited: 57
Understanding the role of dopamine in cancer: past, present and future
Christopher E. Grant, Amy L. Flis, Bríd M. Ryan
Carcinogenesis (2022) Vol. 43, Iss. 6, pp. 517-527
Open Access | Times Cited: 47
Blockage of Autophagy for Cancer Therapy: A Comprehensive Review
Ahmed Hassan, Yuxin Zhao, Xiuping Chen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7459-7459
Open Access | Times Cited: 12
Structural characteristics of a polysaccharide isolated from Potentilla anserina L. and its mitigating effect on Zearalenone-induced oxidative damage in Sertoli cells
Haixia Shi, Zunqiang Yan, Hong Du, et al.
International Journal of Biological Macromolecules (2025), pp. 139752-139752
Closed Access | Times Cited: 1
Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux
Yong Xia, Fuyan Xu, Meiping Xiong, et al.
Pharmacological Research (2020) Vol. 163, pp. 105295-105295
Closed Access | Times Cited: 68
Osteocyte-Driven Downregulation of Snail Restrains Effects of Drd2 Inhibitors on Mammary Tumor Cells
Shengzhi Liu, Yao Fan, Andy Chen, et al.
Cancer Research (2018) Vol. 78, Iss. 14, pp. 3865-3876
Open Access | Times Cited: 49
How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC
Li Chen, Xiaoying Jiang, Yuanheng Li, et al.
Clinical Immunology (2022) Vol. 237, pp. 108962-108962
Closed Access | Times Cited: 27
Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2/M cell cycle arrest, apoptosis, and autophagy
Fuyan Xu, Huizhi Xi, Mengya Liao, et al.
Cancer Chemotherapy and Pharmacology (2022) Vol. 89, Iss. 3, pp. 331-346
Closed Access | Times Cited: 25
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment
Francesca Battaglin, Priya Jayachandran, Carly Strelez, et al.
Oncogene (2022) Vol. 41, Iss. 43, pp. 4769-4778
Open Access | Times Cited: 23
Phenothiazines boost host control of Mycobacterium avium infection in primary human macrophages
Gül Kilinç, Tom H. M. Ottenhoff, Anno Saris
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117941-117941
Closed Access
KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D
Yonglan Wang, Kun Cao
Journal of Immunology Research (2021) Vol. 2021, pp. 1-19
Open Access | Times Cited: 31
Repurposing Antipsychotics for Cancer Treatment
Nikolaos Vlachos, Marios Lampros, Spyridon Voulgaris, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1785-1785
Open Access | Times Cited: 31
CROssBAR: comprehensive resource of biomedical relations with knowledge graph representations
Tunca Doğan, Heval Ataş, Vishal Joshi, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 16, pp. e96-e96
Open Access | Times Cited: 30
Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer
James S. Brown
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104809-104809
Closed Access | Times Cited: 19
Bioelectric pharmacology of cancer: A systematic review of ion channel drugs affecting the cancer phenotype
Karina Kofman, Michael Levin
Progress in Biophysics and Molecular Biology (2024) Vol. 191, pp. 25-39
Closed Access | Times Cited: 4
Central nervous system and immune cells interactions in cancer: unveiling new therapeutic avenues
Ji Wen, Yue Li, Wanli Deng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Trifluoperazine activates AMPK / mTOR / ULK1 signaling pathway to induce mitophagy in osteosarcoma cells
Wen‐Hui Shen, Xiangchen Zeng, Xianhui Zeng, et al.
Chemico-Biological Interactions (2024) Vol. 392, pp. 110904-110904
Closed Access | Times Cited: 3
Cyclin E: a potential treatment target to reverse cancer chemoresistance by regulating the cell cycle.
Wei Pang, Yashan Li, Weihua Guo, et al.
PubMed (2020) Vol. 12, Iss. 9, pp. 5170-5187
Closed Access | Times Cited: 26
Role of reactive oxygen species in tumors based on the ‘seed and soil’ theory: A complex interaction (Review)
Wei Liang, Xinying He, Jianqiang Bi, et al.
Oncology Reports (2021) Vol. 46, Iss. 3
Open Access | Times Cited: 21
From GWAS to drug screening: repurposing antipsychotics for glioblastoma
Wei-Zhi Lin, Yen‐Chun Liu, Meng-Chang Lee, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
The role of USP1 deubiquitinase in the pathogenesis and therapy of cancer
Svitlana Antonenko, М.П. Завелевич, Г. Д. Телегеев
Acta Biochimica Polonica (2023)
Open Access | Times Cited: 8
Trifluoperazine reduces cuprizone-induced demyelination via targeting Nrf2 and IKB in mice
Ehsan Khaledi, Tayebeh Noori, Ahmad Mohammadi-Farani, et al.
European Journal of Pharmacology (2021) Vol. 909, pp. 174432-174432
Closed Access | Times Cited: 19
DRD1 suppresses cell proliferation and reduces EGFR activation and PD‐L1 expression in NSCLC
Christopher E. Grant, Amy L. Flis, Leila Toulabi, et al.
Molecular Oncology (2024) Vol. 18, Iss. 6, pp. 1631-1648
Open Access | Times Cited: 2
Repurposing drugs in autophagy for the treatment of cancer: From bench to bedside
Faqian Bu, Jifa Zhang, Shuai Wen, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 7, pp. 1815-1831
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top